Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1

Status

Completed 14Recruiting 4Withdrawn 3Unknown 3Terminated 3Not yet recruiting 3Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

CNS 2Thoracic 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Drug Delivery Systems × Clear all
NCT05733312 2026-01-30

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Mayo Clinic

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms

NCT06124118 2026-01-08

NOVOCURE

University of Utah

Phase 1 Recruiting
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06525571 2025-11-18

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Johns Hopkins University

Phase 3 Recruiting
200 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT07141732 2025-09-16

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Joint Stock Company European Medical Centre

Phase 1 Recruiting
15 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡